![Jeff Boerneke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Boerneke
General Counsel bei
GOSSAMER BIO, INC.
Profil
Jeff Boerneke is currently Secretary & General Counsel at Gossamer Bio, Inc. since 2021.
Formerly, Mr. Boerneke was General Counsel at Amgen, Inc. from 2015 to 2018 and an Associate at Latham & Watkins LLP.
Education includes undergraduate studies at Point Loma Nazarene University and graduate studies at UCLA School of Law.
Aktive Positionen von Jeff Boerneke
| Unternehmen | Position | Beginn |
|---|---|---|
| GOSSAMER BIO, INC. | General Counsel | 01.04.2018 |
Ehemalige bekannte Positionen von Jeff Boerneke
| Unternehmen | Position | Ende |
|---|---|---|
| AMGEN INC. | General Counsel | 01.01.2018 |
Latham & Watkins LLP
 Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Ausbildung von Jeff Boerneke
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Latham & Watkins LLP
Latham & Watkins LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Point Loma Nazarene University
 Point Loma Nazarene University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA School of Law
 UCLA School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gossamer Bio, Inc.
 Gossamer Bio, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing therapeutics for immunology, inflammation and oncology diseases | Health Technology |
